Have a personal or library account? Click to login
Epidural Anesthesia for Caesarean Section in a Patient with Risk of Malignant Hyperthermia Cover

Epidural Anesthesia for Caesarean Section in a Patient with Risk of Malignant Hyperthermia

Open Access
|Feb 2019

References

  1. 1. Jukic M, Husedžinovic I, Kvolik S, Majeric K.V, Peric M & Žunic J. (2013). Klinicka anesteziologija (2nd ed). Zagreb, Medicinska naklada.
  2. 2. Rosenberg H, Pollock N, Schiemann A, Bulger T. & Stowell K. (2015). Malignant hyperthermia: a review. Orphanet J Rare Dis. 10:93. DOI: 10.1186/s13023-015-0310-1.10.1186/s13023-015-0310-1452436826238698
  3. 3. Kollmann-Carnaiora A, Alsina E, Dominouez A, Del Blanco B, Yepes MJ, Guerrero JL. & Garcia A. (2017). Clinical protocol for the management hyperthermia. Rev Esp Anestesiol Reanim. 64(1):32-40. DOI: 10.1016/j.redar.2016.06.004.10.1016/j.redar.2016.06.00427633384
  4. 4. Metteriein T, Schuster F, Graf BM. & Anetseder M. (2014). Malignant hyperthermia. Anaesthesist. 63(12):908-18. DOI: 10.1007/s00101-014-2392-x.10.1007/s00101-014-2392-x25384957
  5. 5. Harison GG, Isaacs H. (1992). Malignant hyperthermia. An historical vignette. Anaesthesia. 47(1):54-6.
  6. 6. Lalevic P, (1999). Anesteziologija. (1st ed). Beograd. Zavod za udžbenike i nastavna sredstva.
  7. 7. Ording H. (1985). Incidence of malignant hyperthermia in Denmark. Anesth. Analg. 64(7):700-4.4014731
  8. 8. Ibarra MC, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, et al. (2006). Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology. 104(6):1146-54.
  9. 9. Butterworth FJ, Mackey CD. & Wasnick DJ. (2013). Morgan and Mikhails Clinical Anesthesiology. (5th ed). New York. Mc Graw Hill Education.
  10. 10. Miller, Ronald D. (1994). Anesthesia. (4th ed). New York. Churchill Livingstone
  11. 11. Osada H, Masuda K, Seki K, Sekiva S. (2004). Multiminicore disease with susceptibility to malignant hiperthermia in pregnanci. Ginecol Obstet Invest. 58(1):32-5.
  12. 12. Lucy SJ. (1994). Anesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient. Can J Anaesth. 41(12):1220-6.
  13. 13. Bilmen JG, Gillies RI. (2014). Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients. Anaesth Intenzive Care. 42(1):51-8.
  14. 14. Rosaeg OP, Morrison S, MacLeod JP. (1996). Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth. 43(4):403-7.10.1007/BF030117228697558
  15. 15. Foster RN, Boothroyd KP. (2008). Caesarean section in a complicated case of central core disease. Anaesthesia, Journal of Association of Anasethetists of Great Britain and Ireland. 63: 544-7. DOI: 10.1111/j.1365-2044.2007.05411.x10.1111/j.1365-2044.2007.05411.x18412656
  16. 16. Goto S, Ogata K, Fujie T, Fujigaki T, Nakamura H, Yukinari T & Shibata O. (1993). Caesarean section in a patient with past history of fulminant malignant hyperthermia. Masui. 42(2):271-5.
  17. 17. Malignant Hyperthermia Association of the USA-FAQS Molecular Genetics http://www.mhaus.org/faqs/molecular-genetics. Accessed 10 July 2015.
  18. 18. European Malignant Hyperthermia Group http://www.emhg.org. Accessed 10 July 2015.
DOI: https://doi.org/10.1515/sjecr-2017-0012 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 393 - 397
Submitted on: Feb 12, 2017
Accepted on: Apr 24, 2017
Published on: Feb 23, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Aleksandra Vukotic, Milovan Vukotic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.